EEG effects of buspirone and pindolol: A method of examining 5-HT1A receptor function in humans

Psychopharmacology

Volumn 166, Issue 3, 2003, Pages 284-293

  McAllister Williams, R H ^a,b   Massey, A E ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

5 HT; Body temperature; Buspirone; EEG; Growth hormone; Pindolol; Prolactin; Receptors

Indexed keywords

ANTIDEPRESSANT AGENT; BUSPIRONE; GROWTH HORMONE; PINDOLOL; PLACEBO; PROLACTIN; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR;

ADULT; ARTICLE; BODY TEMPERATURE; BRAIN FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFECT; DRUG MECHANISM; ELECTROENCEPHALOGRAM; GROWTH HORMONE BLOOD LEVEL; HUMAN; MALE; NAUSEA; NEUROENDOCRINE SYSTEM; NORMAL HUMAN; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; TIME SERIES ANALYSIS; VERTIGO; VISUAL ANALOG SCALE;

EID: 0037349086     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1339-0     Document Type: Article

References (54)

1. Aghajanian GK, VanderMaelen CP (1982) Intracellular recordings from serotonergic dorsal raphe neurons: pacemaker potentials and the effect of LSD. Brain Res 238:463-469
2. American Electroencephalographic Society (1994) Guideline thirteen: guidelines for standard electrode position nomenclature. J Clin Neurophysiol 11:111-113
3. Anderer P, Barbanoj MJ, Saletu B, Semlitsch HV (1993) Restriction to a limited set of EEG-target variables may lead to misinterpretation of pharmaco-EEG results. Neuropsychobiology 27:112-116
4. Anderson IM, Cowen PJ (1992) Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers. Psychopharmacology 106:428-432
5. Anderson IM, Cowen PJ, Grahame-Smith DG (1990) The effects of gepirone on neuroendocrine function and temperature in humans. Psychopharmacology 100:498-503
6. Anderson IM, Deakin JFW, Miller HE (1996) The effect of chronic fluvoxamine on hormonal and psychological responses to buspirone in normal volunteers. Psychopharmacology 128:74-82
7. Mango V, Underwood MD, Boldrini M, Tamir H, Kassir SA, Hsiung S, Chen JJ, Mann JJ (2001) Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 25:892-903
8. Azmitia EC, Gannon PJ, Kheck NM, Whitaker-Azmitia PM (1996) Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology 14:35-46
9. Blier P, de Montigny C (1994) Current advances in the treatment of depression. Trends Pharmacol 15:220-226
10. Blier P, Seletti B, Gilbert F, Young SN, Benkelfat C (2002) Serotonin (1A) receptor activation and hypothermia in humans. Lack of evidence for a presynaptic mediation. Neuropsychopharmacology 27:301-308
11. Bogdanov NN, Bogdanov MB (1994) The role of 5-HT1A serotonin and D2 dopamine receptors in buspirone effects on cortical electrical activity in rats. Neurosci Lett 177:1-4
12. Burnet PW, Eastwood SL, Lacey K, Harrison PJ (1995) The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain. Brain Res 676:157-168
13. Charney DS, Heninger GR, Sternberg DE (1984) Serotonin function and mechanism of action of antidepressant treatment. Effects of amitriptyline and desipramine. Arch Gen Psychiatry 41:359-365
14. Checkley SA (1980) Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness. Psychol Med 10:35-53
15. Clifford EM, Gartside SE, Umbers V, Cowen PJ, Hajos M, Sharp T (1998) Electrophysiological and neurochemicai evidence that pindolol has agonist properties at the 5-HT(1A) autoreceptor in vivo. Br J Pharmacol 124:206-212
16. Coccaro EF, Gabriel S, Siever LJ (1990) Buspirone challenge: preliminary evidence for a role for central 5-HT1a receptor function in impulsive aggressive behaviour in humans. Psychopharmacol Bull 26:393-405
17. Corradetti R, Laaris N, Hanoun N, Laporte AM, Le Poul E, Hamon M, Lanfumey L (1998) Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain. Br J Pharmacol 123:449-462
18. Cowen PJ, Charig EM (1987) Neuroendocrine responses to intravenous tryptophan in major depression. Arch Gen Psychiatry 44:958-966
19. de Koning P, de Vries MH (1995) A comparison of the neuroendocrinological and temperature effects of DU 29894, flesinoxan, sulpiride and haloperidol in normal volunteers. Br J Clin Pharmacol 39:7-14
20. Deakin JFW, Pennell I, Upadhyaya AJ, Lofthouse R (1990) A neuroendocrine study of 5-HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation. Psychopharmacology 101:85-92
21. Dijk DJ, Beersma DG, Daan S, van den Hoofdakker RH (1989) Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleep stages and EEG power spectra. Eur J Pharmacol 171:207-218
22. Drevets WC, Frank E, Price JC, Kupfer DJ, Greer PJ, Mathis C (2000) Serotonin type-1A receptor imaging in depression. Nucl Med Biol 27:499-507
23. Gillin JC, Jernajczyk W, Valladares-Neto DC, Golshan S, Lardon M, Stahl SM (1994) Inhibition of REM sleep by ipsapirone, a 5HT1A agonist, in normal volunteers. Psychopharmacology 116:433-436
24. Goodwin GM, de Souza RJ, Green AR (1985) Presynaptic serotonin receptor-mediated response in mice attenuated by antidepressant drugs and electroconvulsive shock. Nature 317:531-533
25. Hennig J, Opper C, Huwe S, Netter P (1997) The antagonism of ipsapirone induced biobehavioral responses by ± pindolol in high and low impulsives. J Neural Transm 104:1027-1035
26. Herrmann WM, Fichte K, Kubicki SK (1980) Definition of EEG frequency bands on the interpretation of factor analysis with EEG power spectrum parameters. In: Kubicki S, Herrmann WM, Laudahn G (eds) Faktorenanalyse und variablenbildung aus dem elektroenzephalogramm. Fischer, Stuttgart, pp 61-74
27. Howell DC (1999) Fundamental statistics for the behavioural sciences, 4th edn. Duxbury Press, Pacific Grove, Calif.
28. Koyama T, Meltzer HY (1986) A biochemical and neuroendocrine study of the serotonergic system in depression. In: Hippius H, Klerman GL, Matussek N (eds) New results in depression. Springer, Berlin, pp 169-188
29. Lerer B, Gelfin Y, Gorfine M, Allolio B, Lesch KP, Newman ME (1999) 5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge. Neuropsychopharmacology 20:628-639
30. Maj J, Moryl E (1992) Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations. J Neural Transm [Gen Sect] 88:143-156
31. Martin KF, Phillips I, Hearson M, Prow MR, Heal DJ (1992) Characterization of 8-OH-DPAT-induced hypothermia in mice as a 5-HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressants. Br J Pharmacol 107:15-21
32. Maskall DD, Zis AP, Lam RW, Clark CM, Kuan AJ (1995) Prolactin response to buspirone challenge in the presence of dopaminergic blockade. Biol Psychiatry 38:235-239
33. McAllister-Williams RH, Young AH (1998) The pathology of depression. A synthesis of the role of serotonin and corticosteroids. In: Ebert D, Ebmeier K (eds) New models for depression. Karger, Basel, pp 170-198
34. McAllister-Williams RH, Ashton CH, Ferrier IN (1997) Buspirone affects the EEG power spectrum in healthy volunteers: a 5-HT1A effect? J Psychopharmacol 11:A34-133
35. McCormick DA, Wang Z (1991) Serotonin and noradrenaline excite GABAergic neurones of the guinea-pig and cat nucleus reticularis thalami. J Physiol 442:235-255
36. Meltzer HY, Maes M (1995) Effects of ipsapirone on plasma cortisol and body temperature in major depression. Biol Psychiatry 38:450-457
37. Meltzer HY, Maes M (1996) Effect of pindolol on hormone secretion and body temperature: partial agonist effects. J Neural Transm 103:77-88
38. Meltzer HY, Flemming R, Robertson A (1983) The effect of buspirone on prolactin and growth hormone secretion in man. Arch Gen Psychiatry 40:1099-1102
39. Mizuki Y, Suetsugi M, Ushijima I, Yamada M (1994) Characteristics of the anxiolytic effects of buspirone in high- and low-anxious normal humans assessed by frontal midline theta activity. Meth Find Exp Clin Pharmacol 16:291-300
40. Pasqualetti M, Nardi I, Ladinsky H, Marazziti D, Cassano GB (1996) Comparative anatomical distribution of serotonin 1A, 1D alpha and 2A receptor mRNAs in human brain postmortem. Mol Brain Res 39:223-233
41. Pitchot W, Ansseau M, Gonzalez MA, Lembreghts M, Hansenne M, Wauthy J, Reel C, Jammaer R, Papart P, Sulon J (1995) The flesinoxan 5-HT1A receptor challenge in major depression and suicidal behavior. Pharmacopsychiatry 28:91-92
42. Power AC, Cowen PJ (1992) Neuroendocrine challenge tests: assessment of 5-HT function in anxiety and depression. Mol Aspects Med 13:205-220
43. Price LH, Charney DS, Delgado PL, Heninger GR (1991) Serotonin function and depression: neuroendocrine and mood responses to intravenous l-tryptophan in depressed patients and healthy comparison subjects. Am J Psychiatry 148:1518-1525
44. Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J, Gunn RN, Grasby PM, Cowen PJ (2000) Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 57:174-180
45. Seifritz E, Moore P, Trachsel L, Bhatti T, Stahl SM, Gillin JC (1996) The 5-HT1A agonist ipsapirone enhances EEG slow wave activity in human sleep and produces a power spectrum similar to 5-HT2 blockade. Neurosci Lett 209:41-44
46. Seifritz E, Gillin JC, Rapaport MH, Kelsoe JR, Bhatti T, Stahl SM (1998) Sleep electroencephalographic response to muscarinic and serotonin1A receptor probes in patients with major depression and in normal controls. Biol Psychiatry 44:21-33
47. Seletti B, Benkelfat C, Blier P, Annable L, Gilbert F, de Montigny C (1995) Serotonin1A receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses. Neuropsychopharmacology 13:93-104
48. Semlitsch HV, Anderer P, Schuster P, Presslich O (1986) A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. Psychophysiology 23:695-703
49. Shapira B, Newman ME, Gelfin Y, Lerer B (2000) Blunted temperature and cortisol responses to ipsapirone in major depression: lack of enhancement by electroconvulsive therapy. Psychoneuroendocrinology 25:421-438
50. Sharp T, McQuade R, Bramwell S, Hjorth S (1993) Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo. Arch Pharmacol 348:339-346
51. Smith CE, Ware CJ, Cowen PJ (1991) Pindolol decreases prolactin and growth hormone responses to intravenous 1-tryptophan. Psychopharmacology 103:140-142
52. Tunnicliff G (1991) Molecular basis of buspirone's anxiolytic action. Pharmacol Toxicol 69:149-156
53. Upadhyaya AK, Pennell I, Cowen PJ, Deakin JF (1991) Blunted growth hormone and prolactin responses to 1-tryptophan in depression; a state-dependent abnormality. J Affect Disord 21:213-218
54. Young AH, Sharpley AL, Campling GM, Hockney RA, Cowen PJ (1994) Effects of hydrocortisone on brain 5-HT function and sleep. J Affect Disord 32:139-146